Literature DB >> 12888620

Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences.

Janice Ward1, J Ashley Guthrie, Daniel Wilson, Paul Arnold, J Peter Lodge, Giles J Toogood, Judith I Wyatt, Philip J Robinson.   

Abstract

PURPOSE: To compare the accuracy of four breath-hold magnetic resonance (MR) imaging sequences to establish the most effective superparamagnetic iron oxide (SPIO)-enhanced sequence for detection of colorectal hepatic metastases.
MATERIALS AND METHODS: Thirty-one patients with colorectal hepatic metastases underwent T1-weighted gradient-echo (GRE) and T2-weighted fast spin-echo (FSE) MR imaging before and after SPIO enhancement. Four sequences were optimized for lesion detection: T2-weighted FSE, multiecho data image combination (MEDIC), T2-weighted GRE with an 11-msec echo time (TE), and T2-weighted GRE with a 15-msec TE. Images were reviewed independently by three blinded observers. The accuracy of each sequence was measured by using alternative free-response receiver operating characteristic analysis. All results were correlated with findings at surgery, intraoperative ultrasonography, or histopathologic examination. Differences between the mean results of the three observers were measured by using the Student t test.
RESULTS: Postcontrast T2-weighted GRE sequences were the most accurate and were significantly superior to postcontrast T2-weighted FSE and unenhanced sequences alone (P <.05). For all lesions that were malignant or smaller than 1 cm, respectively, mean accuracies of postcontrast sequences were 0.082 and 0.64 for T2-weighted FSE, 0.90 and 0.78 for MEDIC, 0.92 and 0.80 for GRE with an 11-msec TE, 0.93 and 0.82 for GRE with a 15-msec TE, and 0.81 and 0.62 for unenhanced sequences.
CONCLUSION: Optimized SPIO-enhanced T2-weighted GRE combined with unenhanced T2-weighted FSE MR sequences were the most sensitive. Breath-hold FSE postcontrast sequences offer no improvement in sensitivity compared with unenhanced sequences alone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888620     DOI: 10.1148/radiol.2283020376

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

1.  Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.

Authors:  L Bacigalupo; S Aufort; M C Eberlé; E Assenat; M Ychou; B Gallix
Journal:  Radiol Med       Date:  2010-06-23       Impact factor: 3.469

2.  Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma.

Authors:  Lihong Bu; Jin Xie; Kai Chen; Jing Huang; Zoraida P Aguilar; Andrew Wang; Kin Wai Sun; Mei-Sze Chua; Samuel So; Zhen Cheng; Henry S Eden; Baozhong Shen; Xiaoyuan Chen
Journal:  Contrast Media Mol Imaging       Date:  2012 Jul-Aug       Impact factor: 3.161

3.  Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence.

Authors:  Emilio Quaia; Mirko D'Onofrio; Alessandro Palumbo; Stefania Rossi; Stefano Bruni; Maria Cova
Journal:  Eur Radiol       Date:  2006-03-22       Impact factor: 5.315

4.  Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

Authors:  V O Chan; J P Das; J F Gerstenmaier; J Geoghegan; R G Gibney; C D Collins; S J Skehan; D E Malone
Journal:  Ir J Med Sci       Date:  2012-03-17       Impact factor: 1.568

Review 5.  Using Nanoparticles in Medicine for Liver Cancer Imaging.

Authors:  Farideh Farokhi Moghadam
Journal:  Oman Med J       Date:  2017-07

Review 6.  Imaging diagnosis of colorectal liver metastases.

Authors:  Ling-Hui Xu; San-Jun Cai; Guo-Xiang Cai; Wei-Jun Peng
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

7.  Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: prospective comparison between 1.5-T and 3.0-T images in the same patients.

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Mototaka Miyake; Aine Sakurada; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2010-04-29       Impact factor: 5.315

8.  A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy?

Authors:  Adrian B Cresswell; Fenella K S Welsh; Myrddin Rees
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

Review 9.  Vascular applications of ferumoxytol-enhanced magnetic resonance imaging of the abdomen and pelvis.

Authors:  Andrew W Bowman; Cory R Gooch; Lauren F Alexander; Madhura A Desai; Candice W Bolan
Journal:  Abdom Radiol (NY)       Date:  2020-10-22

Review 10.  Role of surgery in colorectal cancer liver metastases.

Authors:  Özgür Akgül; Erdinç Çetinkaya; Şiyar Ersöz; Mesut Tez
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.